SCHEMBL17828969

SCHEMBL17828969

c1ccc(-c2ccc(-c3nc(-c4ccc(-n5c6ccccc6c6ccc(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)cc65)cc4)nc4ccc5ccccc5c34)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 2/20 0.39
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ATM Q13315 2/20 0.36
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
PTGER4 P35408 1/20 0.36
MAPT P10636 3/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
RECQL P46063 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPY5R Q15761 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
PIK3CD O00329 2/20 0.32
PIK3CA P42336 2/20 0.32
MTOR P42345 2/20 0.32
PIK3CB P42338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17828978 0.99 PTGES (0.40) PTGESMEN1KMT2AATMKDM4E
SCHEMBL17828987 0.97 PTGES (0.41) PTGESMEN1KMT2AATMKDM4E
SCHEMBL17828970 0.96 PTGES (0.42) PTGESMEN1KMT2AATMKDM4E
SCHEMBL17878992 0.95 PTGES (0.42) PTGESMEN1KMT2AATMKDM4E
SCHEMBL17879001 0.95 PTGES (0.42) PTGESMEN1KMT2AATMKDM4E
SCHEMBL17828953 0.93 PTGES (0.39) PTGESMEN1KMT2AATMKDM4E
SCHEMBL17829028 0.93 PTGES (0.39) PTGESMEN1KMT2AATMKDM4E
SCHEMBL17828944 0.93 PTGES (0.39) PTGESMEN1KMT2AATMKDM4E
SCHEMBL17828977 0.92 ATM (0.39) PTGESMEN1KMT2AATMKDM4E
SCHEMBL17828985 0.91 PTGES (0.38) PTGESMEN1KMT2AATMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME L1CAM, LEF1, EML4 PTGES 3205/4885MEN1 94/4885KMT2A 1859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.